Literature DB >> 30689047

The European COPD audit : Adherence to guidelines, readmission risk and hospital care for acute exacerbations in Austria.

Robab Breyer-Kohansal1, Sylvia Hartl2,3, Marie-Kathrin Breyer4, Andrea Schrott5, Michael Studnicka6, Daniel Neunhäuserer6, Gerhard Fülöp7, Otto Chris Burghuber4,3.   

Abstract

OBJECTIVE: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are the major reason for COPD hospitalization and increased risk for readmissions. The organizational structure of Austrian hospitals provides the opportunity to investigate the impact of specialized respiratory care compared to general care on adherence to guidelines and readmission in AECOPD.
METHODS: The data from the European COPD audit, a prospective observational non-interventional cohort trial were analyzed. In total, 823 patients admitted due to AECOPD in 26 hospitals (specialized respiratory care vs. general care) within Austria were included. Patients characteristics and outcomes (length of stay, readmission rate, and mortality) were analyzed in relation to hospital resources (personnel and equipment) and adherence to international guidelines.
RESULTS: Patients admitted to general care had more comorbidities (Charlson comorbidity index: 2.6 ± 1.7 vs. 2.0 ± 1.4; p < 0.05) and a shorter length of stay (10.7 ± 7.8 days vs. 12.0 ± 10.2 days; p < 0.05). Patients admitted to specialized respiratory care more often underwent blood gas analysis and non-invasive ventilation (98.4% vs. 81.5% and 68.6% vs. 26.7%, p < 0.01; respectively). In multivariate analysis, the risk for AECOPD readmission was lower (odds ratio, OR 0.72 [0.51;0.91]; p < 0.05) in patients admitted to specialized respiratory care.
CONCLUSION: A greater adherence to COPD guidelines with respect to blood gas analysis and non-invasive ventilation and decreased AECOPD readmission risk was observed for patients admitted to specialized respiratory care. Adherence to guidelines may have the potential to decrease COPD readmission rates.

Entities:  

Keywords:  COPD; Exacerbation; Guidelines; Hospital care; Treatment

Mesh:

Year:  2019        PMID: 30689047     DOI: 10.1007/s00508-019-1441-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  23 in total

1.  Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study.

Authors:  J Garcia-Aymerich; E Monsó; R M Marrades; J Escarrabill; M A Félez; J Sunyer; J M Antó
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

2.  Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations.

Authors:  C M Roberts; R A Stone; R J Buckingham; N A Pursey; D Lowe
Journal:  Thorax       Date:  2010-11-12       Impact factor: 9.139

3.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

4.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

5.  UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation.

Authors:  L C Price; D Lowe; H S R Hosker; K Anstey; M G Pearson; C M Roberts
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

6.  Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.

Authors:  Héctor Bueno; Joseph S Ross; Yun Wang; Jersey Chen; María T Vidán; Sharon-Lise T Normand; Jeptha P Curtis; Elizabeth E Drye; Judith H Lichtman; Patricia S Keenan; Mikhail Kosiborod; Harlan M Krumholz
Journal:  JAMA       Date:  2010-06-02       Impact factor: 56.272

7.  Evidence for a link between mortality in acute COPD and hospital type and resources.

Authors:  C M Roberts; S Barnes; D Lowe; M G Pearson
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

8.  Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

Authors:  Mona Bafadhel; Susan McKenna; Sarah Terry; Vijay Mistry; Carlene Reid; Pranabashis Haldar; Margaret McCormick; Koirobi Haldar; Tatiana Kebadze; Annelyse Duvoix; Kerstin Lindblad; Hemu Patel; Paul Rugman; Paul Dodson; Martin Jenkins; Michael Saunders; Paul Newbold; Ruth H Green; Per Venge; David A Lomas; Michael R Barer; Sebastian L Johnston; Ian D Pavord; Christopher E Brightling
Journal:  Am J Respir Crit Care Med       Date:  2011-09-15       Impact factor: 21.405

9.  Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trial.

Authors:  Steven Kesten; Bartolome Celli; Marc Decramer; Dacheng Liu; Donald Tashkin
Journal:  Respir Res       Date:  2011-09-28

Review 10.  COPD exacerbations: defining their cause and prevention.

Authors:  Jadwiga A Wedzicha; Terence A R Seemungal
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

View more
  2 in total

Review 1.  Characteristics, Management and In-Hospital Clinical Outcomes Among Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: Results from the Phase I Data of ACURE Study.

Authors:  Chen Liang; Xihua Mao; Hongtao Niu; Ke Huang; Fen Dong; Yahong Chen; Kewu Huang; Qingyuan Zhan; Yin Huang; Yaowen Zhang; Ting Yang; Chen Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-25

2.  Risk factor for 31-day unplanned readmission to hospital in patients with pulmonary tuberculosis in China.

Authors:  Jing Cao; Shengpeng Liu; Juhua Huang
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.